Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2051-5960
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies ; volume:8 ; number:1 ; day:22 ; month:6 ; year:2020 ; pages:1-17 ; date:12.2020
Acta Neuropathologica Communications ; 8, Heft 1 (22.6.2020), 1-17, 12.2020

Urheber
Xia, Yuxing
Prokop, Stefan
Gorion, Kimberly-Marie M.
Kim, Justin D.
Sorrentino, Zachary A.
Bell, Brach M.
Manaois, Alyssa N.
Chakrabarty, Paramita
Davies, Peter
Giasson, Benoit I.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40478-020-00967-w
URN
urn:nbn:de:101:1-2020081822061971221619
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:03 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Xia, Yuxing
  • Prokop, Stefan
  • Gorion, Kimberly-Marie M.
  • Kim, Justin D.
  • Sorrentino, Zachary A.
  • Bell, Brach M.
  • Manaois, Alyssa N.
  • Chakrabarty, Paramita
  • Davies, Peter
  • Giasson, Benoit I.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Verbundene Objekte